Continued boost from sales of the blockbuster drug Revlimid along with launches of a few inhalation drug is expected to fuel a jump in US sales for Dr Reddy#39;s.
Continued boost from sales of the blockbuster drug Revlimid along with launches of a few inhalation drug is expected to fuel a jump in US sales for Dr Reddy#39;s. Continued boost from sales of the blockbuster drug Revlimid along with launches of a few inhalation drug is expected to fuel a jump in US sales for Dr Reddy#39;s. Moneycontrol Latest News Read More
English 
हिन्दी